Login / Signup

Clinical Benefit of Switching from Low-Dose to High-Dose Empagliflozin in Patients with Type 2 Diabetes.

Takeshi MatsumuraTomoko MakabeSeiko UedaYuki FujimotoKayo SadahiroShiori TsuruyamaYuma OokuboTatsuya KondoEiichi Araki
Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
UMIN Clinical Trials Registry (UMIN000041543).
Keyphrases
  • high dose
  • low dose
  • clinical trial
  • stem cell transplantation
  • phase ii
  • randomized controlled trial
  • study protocol